Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma

NCT03909776 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Event-free Survival
Overall Survival
Local-recurrence Free Survival
Pathological Response

Interventions

DRUG: Cisplatin

Sponsor

Peking University People's Hospital